Key Takeaways
- Contact dermatitis has two distinct types: irritant (direct damage to the skin, no immune sensitization required) and allergic (a delayed, T-cell mediated reaction that requires prior sensitization).
- Poison ivy, nickel, and fragrances are among the most common causes of contact dermatitis.
- Patch testing is the gold standard for diagnosing allergic contact dermatitis. The FDA-approved T.R.U.E. Test panel covers 35 allergens, and broader panels find more of the clinically relevant reactions.
- Topical corticosteroid potency should match the body site: stronger agents for thick skin such as the palms and soles, lower-potency agents for the face, eyelids, and skin folds.
- Contact dermatitis is the most common reported occupational skin disease; research suggests it makes up 90 to 95% of occupational skin disease cases.
- Telehealth can assess and treat many presentations of contact dermatitis. Photos combined with a detailed exposure history are often enough to guide initial management.
Contact dermatitis is one of the most common skin conditions seen in clinical practice, and also one of the most misunderstood. Patients often describe it as "just a rash," but behind that rash is either a substance damaging the skin's surface or an immune system mounting an inflammatory response. Those are two different processes, and they require different approaches to diagnosis and treatment.
Contact dermatitis is the most common form of reported occupational skin disease, and research suggests it makes up 90 to 95% of occupational skin disease cases in the U.S.[9] Yet the path from "I touched something and my skin reacted" to an accurate diagnosis and lasting remission is often not straightforward.
The recommendation for patients: the rash is just the signal. The real work is finding the source.
Irritant vs. Allergic Contact Dermatitis: Understanding the Difference
The distinction between irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) is not just academic. It determines whether a patient needs avoidance alone, patch testing, or a different treatment strategy altogether.
Irritant Contact Dermatitis
ICD is a nonspecific skin response to direct damage, without a T-cell (immune) response. No prior sensitization is required, and the likelihood of a reaction rises with the duration, intensity, and concentration of the exposure. The inflammation comes from the skin's own cells: proinflammatory cytokines are released from keratinocytes, usually in response to chemical stimuli.[1]
Clinically, ICD causes burning, stinging, soreness, and pain, and it can also itch. The acute reaction usually peaks within minutes to a few hours of exposure and then starts to heal.[1] Chronic contact dermatitis from repeated exposure looks different: thickened (lichenified) skin with cracks and fissures.[4] This chronic irritant pattern is common on the hands of healthcare workers, who wash and sanitize their hands many times a day.[5]
Allergic Contact Dermatitis
ACD is a delayed-type (type IV) hypersensitivity reaction mediated by T cells. Two sequential phases drive the disease:
- Sensitization phase: On first exposure, a small molecule (a "hapten") links to skin proteins and forms an antigen complex.[4] Cutaneous dendritic cells capture the antigen and migrate to the draining lymph nodes, where antigen-specific effector T cells are induced.[1] This phase produces no visible rash.
- Elicitation phase: On a later exposure to the same allergen, effector T cells are activated in the skin and produce chemical mediators that create antigen-specific inflammation: redness, swelling, oozing, crusting, and vesicles. Lesions usually appear 24 to 72 hours after exposure and peak at about 72 to 96 hours.[1]
Itching is usually more prominent in ACD than in ICD.[1] Once a person is sensitized, re-exposure to the allergen brings the rash back, which is why identifying and avoiding the causative substance is the priority.[4]
| Feature | Irritant Contact Dermatitis | Allergic Contact Dermatitis |
|---|---|---|
| Mechanism | Direct chemical or physical damage to the skin; no T-cell response | Type IV delayed hypersensitivity (T-cell mediated) |
| Prior sensitization needed? | No; a first exposure can cause a reaction | Yes; requires an earlier sensitization phase |
| Onset after exposure | Peaks within minutes to a few hours | Appears 24 to 72 hours after exposure; peaks at about 72 to 96 hours[1] |
| Predominant symptom | Burning, stinging, soreness, pain | Itching (pruritus) is more prominent |
| Who is at risk? | Anyone exposed to enough of an irritant for long enough | Only people already sensitized to that allergen; contact allergy is common in the general population[3] |
| Patch testing | Not diagnostic (no allergy involved) | Gold standard for identifying the allergen |
In clinical practice, the two types often coexist. Repeated wet work can cause ICD that damages the skin barrier, and an allergic reaction can develop on top of it. Sorting out which process is dominant matters for treatment planning.
Common Contact Allergens: What Triggers Allergic Contact Dermatitis
Thousands of substances are known contact allergens, but in clinical practice a smaller group causes most reactions. The most common substances that cause contact dermatitis include poison ivy, nickel, and fragrances.[4] Knowing these patterns helps narrow the possibilities before patch testing confirms the diagnosis.
Nickel
Nickel is the most common metal in costume jewelry that causes allergic contact dermatitis.[1] Less expensive jewelry, and metal belt buckles and pant closures containing nickel, commonly cause allergic contact dermatitis, and nickel is also a component of other metals, including white gold and German silver.[4] The rash typically appears where skin touches the metal, such as the earlobes, the skin around the navel, or the wrists. Inexpensive kits that use dimethylglyoxime to test metal objects for nickel are widely available. Once sensitized, a patient can cover metal tabs (for example, with an iron-on patch over the metal tab of jeans) or avoid nickel-containing items.[4]
Fragrances and Preservatives
Fragrances are among the most common causes of contact dermatitis.[4] Balsam of Peru is also a common cause of allergic contact dermatitis.[1] Exposure comes mainly from personal care products such as soaps, shampoos, lotions, perfumes, and cosmetics. Preservatives such as formaldehyde are also included on the T.R.U.E. Test panel.[4]
Rubber Accelerators
Rubber gloves are a staple at work and at home, and the chemicals used to make rubber can cause contact allergy. Standard patch test kits include chemicals present in rubber,[1] and the T.R.U.E. Test panel includes a black rubber mix.[4] Healthcare workers, food service employees, and anyone who wears gloves for long periods are exposed. In a hospital quality-improvement project on irritant hand dermatitis in healthcare workers, switching from latex to nitrile gloves was one of four workplace changes, alongside gentler hand hygiene products.[5]
Topical Medications
Neomycin is a common over-the-counter topical antibiotic.[4] Neomycin and bacitracin applied to stasis dermatitis or leg ulcers can cause allergic contact dermatitis on the legs and feet.[1] In practice, when a patient reports that a wound "got worse" after applying a triple antibiotic ointment, allergic contact dermatitis to one of its ingredients is worth considering.
Urushiol: Poison Ivy, Oak, and Sumac
Urushiol is the substance in the sap of poison ivy, poison oak, and poison sumac, and exposure to it is a common cause of allergic contact dermatitis.[4] A large share of adults are sensitive to poison ivy or poison oak.[1] In a sensitized person, the reaction usually develops 12 to 48 hours after exposure and lasts two to three weeks. Urushiol can stick to pet fur and objects, and you can transfer it to other parts of your body with your fingers.[6]
One persistent misconception: fluid from poison ivy blisters spreads the rash. It does not. Pus that oozes from blisters doesn't contain urushiol and won't spread the rash. New patches are more likely to come from urushiol still on the fingers, under the nails, or on clothing and other objects.[6]
Within 30 minutes after exposure to urushiol, use soap and water to gently wash the resin off your skin, and scrub under your fingernails too. Even washing after an hour or so can help reduce the severity of the rash. Wash clothing, tools, and gear that may have been contaminated: urushiol can remain potent for years, and an uncleaned object can still cause a skin reaction years later.[6]
Patch Testing: When to Refer and How It Works
Patch testing is considered the gold standard for diagnosing allergic contact dermatitis.[1] It is not a blood test or a skin prick test. It deliberately reproduces the delayed allergic reaction under controlled conditions.
When Is Patch Testing Indicated?
Patch testing is appropriate when:
- Avoiding a suspected substance and initial treatment have not cleared the dermatitis[4]
- The allergen remains unknown despite a careful exposure history[4]
- Occupational exposure is suspected as a contributing cause
- A patient may be reacting to a topical medication; contact sensitization to topical corticosteroids is rare but can occur[7]
- Dermatitis is persistent or recurrent and allergen exposure cannot be excluded
The T.R.U.E. Test Panel
The T.R.U.E. Test (Thin-layer Rapid Use Epicutaneous Test) is a commercially available, FDA-approved patch test panel of 35 allergens plus a negative control.[2] Standard patch test kits include chemicals present in metals such as nickel, rubber, leather, and other everyday materials.[1]
The T.R.U.E. Test is convenient and standardized, but it has a key limitation: North American Contact Dermatitis Group (NACDG) data show it detects only part of the clinically relevant reactions identified on the more extensive NACDG panel, so it may miss relevant allergens.[2] For patients with occupational or complex presentations, a specialist may add occupation-specific or custom allergen series.
How the Test Is Performed
Patch testing usually requires three office visits over about one week.[2] Patches are removed at 48 hours, and final results are read 48 to 72 hours later.[1] Some allergens need delayed readings.[2]
A positive result is only meaningful if it fits the patient's clinical history. The physician must decide whether the allergen is actually present in the patient's environment. This interpretation step is the most important part of the process, and it drives the avoidance counseling that makes the difference between treatment success and failure.
Patch testing is time-consuming, and patients cannot shower normally during the test period.[4] Ask the testing clinic in advance which medicines and skin treatments to stop before the test.
Treatment: The Corticosteroid Potency Ladder, Calcineurin Inhibitors, and Wet Wraps
Treatment starts with one non-negotiable step: identify and avoid the causative substance.[4] Without avoidance, no medication provides lasting benefit. That said, controlling the inflammation while avoidance takes effect is both necessary and achievable.
Topical Corticosteroids: Matching Potency to Location
Localized acute allergic contact dermatitis is successfully treated with mid- or high-potency topical steroids, such as triamcinolone 0.1% or clobetasol 0.05%. The evidence is weaker for the irritant type: there are insufficient data to support topical steroids for irritant contact dermatitis.[4] The challenge is matching potency to the body site, because the risk of side effects rises with prolonged use, a large area of application, higher potency, occlusion, and thinner skin such as the face and genitals.[7]
| Potency Class | Examples | Appropriate Location | Cautions |
|---|---|---|---|
| Class I (Super-high) | Clobetasol propionate 0.05%, augmented betamethasone dipropionate 0.05% ointment | Severe disease and thick skin such as the palms and soles | No more than three weeks at a time; side effects more likely on thin skin such as the face and genitals[7] |
| Class II (High) | Fluocinonide 0.05%, halcinonide 0.1%, betamethasone dipropionate 0.05% ointment | Localized acute allergic contact dermatitis away from thin skin[4] | No more than 12 weeks at a time[7] |
| Class III to V (Medium) | Triamcinolone acetonide 0.1%, mometasone furoate 0.1%, betamethasone valerate 0.1%, fluticasone propionate 0.05% cream | Localized acute allergic contact dermatitis away from thin skin[4] | No more than 12 weeks at a time[7] |
| Class VI to VII (Low) | Desonide 0.05%, hydrocortisone 1% or 2.5% | Thinner skin: face, eyelids, skin folds, and the anogenital region[4] | No specified time limit[7]; still use as directed by your clinician |
The principle I follow: use the potency that the severity and location call for, get control, then step down. A low-potency agent on a thick plaque on the hand may do little. A high-potency agent on the thin skin around the eyes raises the risk of side effects, which for topical corticosteroids include skin atrophy and striae, and eye problems such as cataracts and glaucoma. Topical corticosteroids are usually applied once or twice per day.[7]
For poison ivy and other allergic contact dermatitis that covers an extensive area of skin (greater than 20 percent), topical treatment is usually not enough: systemic steroid therapy is often required and offers relief within 12 to 24 hours.[4]
Topical Calcineurin Inhibitors (TCIs)
Tacrolimus ointment and pimecrolimus cream are immunomodulating drugs that inhibit calcineurin, and they are helpful in allergic contact dermatitis.[1] Tacrolimus works by inhibiting T-lymphocyte activation. Its FDA label indicates tacrolimus 0.1% ointment as second-line therapy for moderate to severe atopic dermatitis, so its use for contact dermatitis is off-label.[8]
The label directs applying a thin layer to the affected skin twice daily and says continuous long-term use of topical calcineurin inhibitors should be avoided.[8]
Patients often ask about the boxed warning on these medicines. The label explains that although a causal relationship has not been established, rare cases of malignancy (for example, skin cancer and lymphoma) have been reported in patients treated with topical calcineurin inhibitors.[8] Talk through the risks and benefits with your clinician before starting one.
Wet Wrap Therapy
Wet wraps and other occlusive methods, such as plastic wrap, bandages, or gloves placed over a topical corticosteroid, increase how much of the medicine gets into the skin.[7] That can help a severe, localized flare, but occlusion also raises the risk of corticosteroid side effects.[7]
Use occlusion only when your clinician recommends it and tells you how long to leave it on.
Systemic Therapy
Oral corticosteroids, typically prednisone, are used when allergic contact dermatitis is severe or extensive. An American Family Physician review recommends prednisone 0.5 to 1 mg per kg daily for five to seven days, after which the dose may be reduced by 50 percent for the next five to seven days. In severe poison ivy (rhus) dermatitis, prednisone should be tapered over two to three weeks, because stopping steroids too quickly can cause rebound dermatitis. The same review advises that a steroid dose pack has insufficient dosing and duration and should not be prescribed.[4]
Antihistamines such as hydroxyzine and cetirizine are often recommended to control itching,[1] but they are generally not effective for the itch of allergic contact dermatitis, and the sedation from some antihistamines may be what gives some patients relief.[4] They do not treat the underlying inflammation.
Occupational Contact Dermatitis: Healthcare Workers, Hairdressers, and Construction
Contact dermatitis is the most common form of reported occupational skin disease, and research suggests it makes up 90 to 95% of occupational skin disease cases.[9] The long-term prognosis of occupational contact dermatitis is often very poor,[5] which is why early recognition and workplace changes matter.
Healthcare Workers
Occupational hand dermatitis is common among healthcare workers, and its incidence increased during the COVID-19 pandemic. Irritant contact dermatitis accounts for the majority of cases and is largely due to frequent contact with hand hygiene products.[5]
In a quality-improvement project of 21 healthcare workers with likely occupational irritant hand dermatitis at one hospital, four workplace changes were used: a gentler alcohol-based hand rub, alternating hand rub with gentle hand wash products, temporarily reduced clinical work, and switching from latex to nitrile gloves. All participants improved, with an estimated mean 80% reduction in signs and symptoms after two months.[5] This was a small project without a comparison group, so the size of the benefit is uncertain. Workers whose dermatitis does not clear, or whose allergen remains unknown, are candidates for patch testing.[4]
Hairdressers
Hairdressers face a dual hazard: irritation from repeated wet work, and allergy to sensitizing chemicals. Paraphenylenediamine (PPD) in hair dye is a common cause of allergic contact dermatitis on the scalp, face, and ears.[1] Some hairdressers have also developed allergic hand eczema from prolonged contact with nickel-containing tools such as scissors.[4]
For a hairdresser with a suspected dye allergy, early patch testing and a switch away from the responsible product can help protect the ability to keep working.
Construction Workers
Construction workers have a substantial risk of developing irritant and allergic contact dermatitis. In a German register of occupational skin disease, potassium dichromate (a chromium compound) caused roughly half of the occupationally relevant sensitizations in the construction industry, followed by epoxy resin and cobalt chloride.[10]
Adding ferrous sulphate to cement lowers its chromium VI content, and in Scandinavian countries the prevalence of dichromate sensitization declined after this change.[10]
Prevention Strategies and Barrier Creams
For patients with confirmed contact allergens, the path to lasting remission runs through avoidance. That sounds simple, but nickel and fragrance turn up in many everyday products, and occupational allergens can be hard to eliminate without changing how work is done. Effective prevention requires knowing exactly what to avoid and where it hides.
Personalized Avoidance Counseling
Following a positive patch test, patients should receive a personal avoidance plan that names the allergen, its common sources in personal care and household products, and safe alternatives. Tools such as the American Contact Dermatitis Society's Contact Allergen Management Program (CAMP) and SkinSAFE are examples used to build these plans.[2]
Skin Barrier Protection at Work
Emollients, moisturizers, or barrier creams may be used as secondary prevention strategies.[4] Barrier creams are not a substitute for avoiding the trigger.
Gloves are a key physical barrier, but glove choice matters. To help prevent irritant hand dermatitis, wear nonlatex gloves when working with potentially irritating substances such as solvents, soaps, and detergents.[4] For people allergic to a rubber chemical, patch test results guide which glove materials are safe.
Emollient Maintenance
Regular moisturizing supports the skin barrier. Keeping hands clean, dry, and well moisturized when possible is part of preventing irritant hand dermatitis,[4] and emollients hydrate the skin.[1] In workplaces, keeping moisturizers within easy reach makes regular use more likely.
- Rash involving the eyes, mouth, or genitals: see a doctor promptly[6]
- Rash or blisters covering a large area of skin: systemic treatment is often needed[4]
- Signs of infection: blisters oozing pus, or a fever greater than 100 F (37.8 C)[6]
- Difficulty breathing after inhaling smoke from burning poison ivy, oak, or sumac: seek emergency medical attention (call 911)[6]
- Persistent or recurrent dermatitis despite apparent allergen avoidance: patch testing may be needed to identify the cause[4]
- Occupation is at risk: early evaluation helps identify the cause while workplace changes are still possible
The Role of Telehealth in Dermatology Assessment
Contact dermatitis is well suited to telehealth evaluation for many, though not all, presentations. The two pillars of clinical assessment are the appearance and distribution of the rash and a detailed exposure history. Both can be captured effectively through a structured virtual visit.
High-quality photographs of the affected skin, taken in natural light, allow a physician to assess distribution, morphology (erythema, vesicles, lichenification), and severity. A focused history covering symptom onset and timeline, potential exposures in the hours to days before onset, occupational environment, personal care products recently changed or added, and any prior similar reactions provides the clinical context needed to develop a differential diagnosis and initial treatment plan.
Telehealth is particularly effective for:
- Suspected poison ivy, oak, or sumac, where the exposure history and rash pattern are often telling
- Nickel allergy from new jewelry or accessories
- Irritant hand dermatitis in patients with known occupational wet work
- Facial or eyelid dermatitis from a recently changed personal care product
- Follow-up visits after initial in-person evaluation to assess treatment response
When telehealth reaches its limits, specifically when the allergen cannot be identified, when the dermatitis does not respond to appropriate treatment, or when occupational disease requires formal patch testing, a referral to an in-person dermatologist or allergist is the right next step. Telehealth and in-person care are not competing approaches; they work best in sequence.
Early evaluation also helps sort out severity, because allergic contact dermatitis covering an extensive area often needs systemic treatment rather than creams alone.[4]
Frequently Asked Questions
Irritant contact dermatitis is direct damage to the skin: no immune sensitization is required, and the chance of a reaction rises with the duration, intensity, and concentration of the exposure. Allergic contact dermatitis is a delayed, T-cell mediated reaction that only occurs in people previously sensitized to a specific allergen. Irritant reactions tend to burn and sting and peak within minutes to hours. In allergic reactions itching is more prominent, and the rash usually appears 24 to 72 hours after re-exposure.[1]
The most common substances that cause contact dermatitis include poison ivy, nickel, and fragrances. Nickel shows up in less expensive jewelry, belt buckles, and pant closures, and neomycin, a common over-the-counter topical antibiotic, is another frequent cause.[4] Balsam of Peru, chromium, paraphenylenediamine (PPD) in hair dye, and chemicals in rubber are also common culprits.[1]
Patch testing is worth considering when avoiding a suspected trigger and initial treatment have not cleared the rash, or when the allergen remains unknown.[4] It usually requires three office visits over about one week, and choosing the allergens and interpreting the results takes specialized training.[2]
Potency selection depends on body site and severity. Super-high-potency agents such as clobetasol propionate 0.05% are useful for severe disease and thick skin such as the palms and soles, for no more than three weeks at a time. Low-potency agents such as hydrocortisone or desonide suit thin skin such as the face and groin. Side effects such as skin atrophy and striae become more likely with higher potency, longer use, larger areas, occlusion, and thin skin.[7] Localized acute allergic contact dermatitis elsewhere is usually treated with a mid- or high-potency agent such as triamcinolone 0.1%.[4]
Yes. Tacrolimus ointment and pimecrolimus cream are non-steroid calcineurin inhibitors that are helpful in allergic contact dermatitis.[1] Tacrolimus ointment is FDA-labeled as second-line therapy for atopic dermatitis, so its use for contact dermatitis is off-label, and its label carries a boxed warning about rare reported cases of malignancy, although a causal relationship has not been established.[8] For mild cases, identifying and avoiding the cause, plus regular moisturizing, may be enough.
Within 30 minutes, gently wash the skin with soap and water, and scrub under your fingernails. Washing even after an hour or so can still help reduce the severity of the rash. Wash clothing, tools, and gear that may have touched the plant, because urushiol can remain potent for years. Pus that oozes from blisters doesn't contain urushiol and won't spread the rash.[6]
Occupational hand dermatitis is common among healthcare workers, and the irritant type, largely due to frequent contact with hand hygiene products, accounts for the majority of cases. In one small hospital project, a gentler hand rub, alternating it with gentle hand wash products, temporarily reduced clinical work, and switching from latex to nitrile gloves were followed by improvement in all participants.[5] Workers whose dermatitis does not clear, or whose allergen remains unknown, are candidates for patch testing.[4]
Many cases of contact dermatitis can be assessed and managed remotely. A physician can review symptom onset and timeline, evaluate high-quality photos of the affected skin, and prescribe appropriate topical treatments, antihistamines, or, when needed, a course of oral corticosteroids without an in-person visit. Telehealth works well for suspected poison ivy, nickel allergy from new jewelry, or irritant hand dermatitis. When patch testing is needed to identify an unknown allergen, an in-person referral can be arranged as the appropriate next step.
References
- Litchman G, Nair PA, Atwater AR, Bhutta BS. Contact Dermatitis. StatPearls. Treasure Island (FL): StatPearls Publishing; last updated September 4, 2023. Accessed November 7, 2026. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459230/
- Steele R, Pacheco K, Sher E, Ross J, Tanzer R, Fonacier L, Aquino MR. Contact Dermatitis and Patch Testing Education: A Work Group Report From the Allergic Skin Diseases Committee of the AAAAI. J Allergy Clin Immunol Pract. 2025;13(8):1970-1979. doi:10.1016/j.jaip.2025.03.055. Available at: https://www.aaaai.org/Aaaai/media/..
- Uter W, Werfel T, White IR, Johansen JD. Contact Allergy: A Review of Current Problems from a Clinical Perspective. Int J Environ Res Public Health. 2018;15(6):1108. Available at: https://pubmed.ncbi.nlm.nih.gov/29844295/
- Usatine RP, Riojas M. Diagnosis and Management of Contact Dermatitis. Am Fam Physician. 2010;82(3):249-255. PMID: 20672788. Available at: https://www.aafp.org/pubs/afp/issues/2010/0801/p249.html
- Loi AST, Aribou ZM, Fong YT. Improving Recovery of Irritant Hand Dermatitis in Healthcare Workers With Workplace Interventions During the COVID-19 Pandemic. Front Public Health. 2022;10:844269. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9340064/
- Mayo Clinic. Poison ivy rash: Symptoms and causes. May 15, 2024. Accessed November 7, 2026. Available at: https://www.mayoclinic.org/diseases-conditions/poison-ivy/symptoms-causes/syc-20376485
- Stacey SK, McEleney M. Topical Corticosteroids: Choice and Application. Am Fam Physician. 2021;103(6):337-343. PMID: 33719380. Available at: https://www.aafp.org/pubs/afp/issues/2021/0315/p337.html
- Encube Ethicals, Inc. Tacrolimus ointment 0.1% [prescribing information]. DailyMed, U.S. National Library of Medicine. Updated October 2025. Accessed November 7, 2026. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43b38551-6c5e-48a4-a453-9286f1c16b34
- Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Skin Exposures and Effects. Last reviewed March 4, 2026. Accessed November 7, 2026. Available at: https://www.cdc.gov/niosh/topics/skin/
- Bock M, Schmidt A, Bruckner T, Diepgen TL. Occupational skin disease in the construction industry. Br J Dermatol. 2003;149(6):1165-1171. Available at: https://pubmed.ncbi.nlm.nih.gov/14674893/